JPH0432067B2 - - Google Patents
Info
- Publication number
- JPH0432067B2 JPH0432067B2 JP58160672A JP16067283A JPH0432067B2 JP H0432067 B2 JPH0432067 B2 JP H0432067B2 JP 58160672 A JP58160672 A JP 58160672A JP 16067283 A JP16067283 A JP 16067283A JP H0432067 B2 JPH0432067 B2 JP H0432067B2
- Authority
- JP
- Japan
- Prior art keywords
- liquid crystal
- substituted phenyl
- isoxazole
- fluorophenyl
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004973 liquid crystal related substance Substances 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 16
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims description 11
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000002858 crystal cell Anatomy 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004990 Smectic liquid crystal Substances 0.000 description 3
- -1 ester-based Chemical class 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910000423 chromium oxide Inorganic materials 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- GWXUVWKBVROFDM-UHFFFAOYSA-N 4-hexoxybenzaldehyde Chemical compound CCCCCCOC1=CC=C(C=O)C=C1 GWXUVWKBVROFDM-UHFFFAOYSA-N 0.000 description 1
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 1
- XXUSEPRYHRDKFV-CTYIDZIISA-N C1C[C@@H](CCC)CC[C@@H]1C1=CC=C(C#N)C=C1 Chemical compound C1C[C@@H](CCC)CC[C@@H]1C1=CC=C(C#N)C=C1 XXUSEPRYHRDKFV-CTYIDZIISA-N 0.000 description 1
- FURZYCFZFBYJBT-JCNLHEQBSA-N C1C[C@@H](CCCCC)CC[C@@H]1C1=CC=C(C#N)C=C1 Chemical compound C1C[C@@H](CCCCC)CC[C@@H]1C1=CC=C(C#N)C=C1 FURZYCFZFBYJBT-JCNLHEQBSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 150000008062 acetophenones Chemical class 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- IGARGHRYKHJQSM-UHFFFAOYSA-N cyclohexylbenzene Chemical compound C1CCCCC1C1=CC=CC=C1 IGARGHRYKHJQSM-UHFFFAOYSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000002547 isoxazolines Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Liquid Crystal Substances (AREA)
Description
【発明の詳細な説明】
本発明は正の誘電異方性を示す新規な液晶物質
及びそれを含有する液晶組成物に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel liquid crystal material exhibiting positive dielectric anisotropy and a liquid crystal composition containing the same.
液晶物質が有する光学異方性及び誘電異方性を
利用した液晶表示素子の表示方式にはTN型、
DS型、ゲスト−ホスト型、二周波法型、DAP
型、ホワイト・テイラー型などの各種の方式があ
り、それぞれの方式により使用される液晶物質に
要求される性質が異なる。例えば表示素子の種類
によつて、液晶物質として誘電異方性が正のもの
を必要としたり、負のものを必要としたり、或い
はその中間的な値のものが適したりする。そして
使用される液晶物質はできるだけ広い温度範囲で
液晶相を示し、又水分、熱、空気、光などに対し
て安定である必要がある。現在のところ単一化合
物でこの様な条件をすべて満たすものはなく、数
種の液晶化合物や非液晶化合物を混合して実用に
供している。 Display methods of liquid crystal display elements that utilize the optical anisotropy and dielectric anisotropy of liquid crystal materials include TN type,
DS type, guest-host type, dual frequency method type, DAP
There are various methods such as type, White-Taylor type, etc., and each method requires different properties of the liquid crystal material used. For example, depending on the type of display element, a liquid crystal material with positive or negative dielectric anisotropy may be required, or a material with an intermediate value may be suitable. The liquid crystal material used must exhibit a liquid crystal phase over as wide a temperature range as possible, and must be stable against moisture, heat, air, light, etc. At present, there is no single compound that satisfies all of these conditions, and several types of liquid crystal compounds and non-liquid crystal compounds are mixed and put into practical use.
最近、広い温度範囲、すなわち低温から高温に
わたつて動作する液晶表示素子がますます要求さ
れる様になつてきた。更に表示素子を駆動させる
のに必要なしきい値電圧、飽和電圧をより低くで
きる液晶組成物が求められている。 Recently, there has been an increasing demand for liquid crystal display elements that operate over a wide temperature range, that is, from low to high temperatures. Furthermore, there is a need for a liquid crystal composition that can lower the threshold voltage and saturation voltage required to drive a display element.
本発明の目的は液晶組成物の透明点を上昇さ
せ、また該液晶組成物を用いた液晶表示素子の駆
動電圧を低下させることができる新規な液晶化合
物を提供することである。 An object of the present invention is to provide a novel liquid crystal compound that can increase the clearing point of a liquid crystal composition and reduce the driving voltage of a liquid crystal display element using the liquid crystal composition.
本発明の第一は、一般式
(式中、XまたはYのいずれか一方は炭素数1〜
15のアルキル基又はアルコキシ基を示し、他方は
はフツ素を示す。)で表わされる3−(p−置換フ
エニル)−5−(p′−置換フエニル)イソオキサゾ
ールである。 The first aspect of the present invention is the general formula (In the formula, either X or Y has 1 to 1 carbon atoms.
15 represents an alkyl group or an alkoxy group, and the other represents fluorine. ) is 3-(p-substituted phenyl)-5-(p'-substituted phenyl)isoxazole.
本発明の第二は、一般式(式中、XとYは前
記の意味をもつ。)で表わされる3−(p−置換フ
ニエル)−5−(p′−置換フエニル)イソオキサゾ
ールを含有することを特徴とする液晶組成物であ
る。 The second aspect of the present invention contains 3-(p-substituted phenyl)-5-(p'-substituted phenyl)isoxazole represented by the general formula (wherein X and Y have the above-mentioned meanings). This is a liquid crystal composition characterized by the following.
本発明の化合物は、他の液晶化合物、例えばエ
ステル系、シツフ塩基系、ビフエニル系、フエニ
ルシクロヘキサン系、複素環系などの液晶化合物
との相溶性に優れ、他の液晶化合物と混合した組
成物を用いた液晶表示素子の使用上限温度を上昇
させ、また、その駆動電圧を低下させることがで
きる。 The compound of the present invention has excellent compatibility with other liquid crystal compounds, such as ester-based, Schiff base-based, biphenyl-based, phenylcyclohexane-based, and heterocyclic-based liquid crystal compounds, and can be used in compositions mixed with other liquid crystal compounds. It is possible to increase the upper limit temperature for use of a liquid crystal display element using the present invention, and to lower the driving voltage thereof.
これらの効果のほかに屈折率異方性(以下△n
と略記する)の大なることから、液晶セルの基板
間隔不均一による色むらが生じにくいという利点
もある。 In addition to these effects, refractive index anisotropy (hereinafter △n
) is large, which also has the advantage that color unevenness due to non-uniform substrate spacing of the liquid crystal cell is less likely to occur.
次に本発明の化合物の製造法について述べる。
p−置換ベンズアルデヒドとp−置換アセトフエ
ノンとをエタノール水溶液中で水酸化ナトリウム
の存在下に加熱することにより、p−置換ベンザ
ル−p′−置換アセトフエノンをつくる。次いで、
この化合物をエタノール水溶液中で水酸化カリウ
ムの存在下、塩酸ヒドロキシルアミンと加熱する
ことにより、3−(p−置換フエニル)−5−
(p′−置換フエニル)イソオキサゾリンが得られ
る。さらにこのイソオキサゾリンを酢酸溶液中で
酸化クロムと加熱することにより、目的の3−
(p−置換フエニル)−5−(p′−置換フエニル)
イソオキサゾールが得られる。 Next, a method for producing the compound of the present invention will be described.
A p-substituted benzal-p'-substituted acetophenone is prepared by heating a p-substituted benzaldehyde and a p-substituted acetophenone in an aqueous ethanol solution in the presence of sodium hydroxide. Then,
By heating this compound with hydroxylamine hydrochloride in the presence of potassium hydroxide in an aqueous ethanol solution, 3-(p-substituted phenyl)-5-
A (p′-substituted phenyl)isoxazoline is obtained. Furthermore, by heating this isoxazoline with chromium oxide in an acetic acid solution, the desired 3-
(p-substituted phenyl)-5-(p'-substituted phenyl)
Isoxazole is obtained.
これを化学式で示すと次のようになる。 This can be expressed as a chemical formula as follows.
以下に実施例により本発明を更に詳細に説明す
る。 The present invention will be explained in more detail below using Examples.
実施例 1
3−(p−フルオロフエニル)−5−(p′−ヘキ
シルオキシフエニル)イソオキサゾール
3−(p−フルオロフエニル)−5−(p′−ヘキ
シルオキシフニエル)イソオキサゾリン5.0gを
酢酸200mlに溶解後、酸化クロム3.0gを加え、
80℃にて、1時間撹拌を行なつた。撹拌終了後、
反応溶液を氷水600mlにあけ、過により得た沈
澱をトルエン100mlに溶解させ、水洗水が中性に
なるまで洗浄した。次いでトルエンを減圧留去
し、残つた固体を酢酸エチルで3回再結晶して目
的の3−(p−フルオロフエニル)−5−(p′−ヘ
キシルオキシフエニル)イソオキサゾール1.6g
(32%)を得た。相転移点は、結晶−スメクチツ
ク点:88.0℃、スメクチツク−透明点:154.6℃
であつた。Example 1 3-(p-fluorophenyl)-5-(p'-hexyloxyphenyl)isoxazole 3-(p-fluorophenyl)-5-(p'-hexyloxyphenyl)isoxazoline 5.0 Dissolve g in 200 ml of acetic acid, add 3.0 g of chromium oxide,
Stirring was performed at 80°C for 1 hour. After stirring,
The reaction solution was poured into 600 ml of ice water, and the precipitate obtained by filtration was dissolved in 100 ml of toluene and washed until the washing water became neutral. Next, toluene was distilled off under reduced pressure, and the remaining solid was recrystallized three times from ethyl acetate to obtain 1.6 g of the desired 3-(p-fluorophenyl)-5-(p'-hexyloxyphenyl)isoxazole.
(32%). The phase transition point is crystal-smectic point: 88.0℃, smectic-clearing point: 154.6℃
It was hot.
出発物質として用いた3−(p−フルオロフエ
ニル)−5−(p′−ヘキシルオキシフエニル)イソ
オキサゾリンは次の如くして製造した。 3-(p-fluorophenyl)-5-(p'-hexyloxyphenyl)isoxazoline used as a starting material was prepared as follows.
(a) p−ヘキシルオキシベンズアルデヒド30.9g
とp−フルオロフエノン20.7gのエタノール溶
液150mlに水酸化ナトリウム16gの水溶液100ml
を加え3時間還流した。冷却後トルエン200ml
を加え、水洗水が中性になるまで洗浄した。次
いでトルエンを減圧留去した後、残渣をメタノ
ールで2回結晶してp−ヘキシルオキシベンザ
ル−p′−フルオロアセトフエノン33g(67%)
を得た:融点74℃。(a) 30.9g p-hexyloxybenzaldehyde
and 150 ml of an ethanol solution of 20.7 g of p-fluorophenone and 100 ml of an aqueous solution of 16 g of sodium hydroxide.
was added and refluxed for 3 hours. 200ml of toluene after cooling
was added and washed until the washing water became neutral. After the toluene was distilled off under reduced pressure, the residue was crystallized twice from methanol to obtain 33 g (67%) of p-hexyloxybenzal-p'-fluoroacetophenone.
Obtained: melting point 74°C.
(b) p−ヘルシルオキシベンザル−p′−フルオロ
アセトフエノン33gのエタノール溶液300mlに
塩酸ヒドロキシルアミ11g、水酸化カリウム20
gの水溶液100mlを加え3時間還流した。冷却
後、過し沈澱をトルエン100mlに溶解させ、
水洗水が中性になるまで洗浄した。次いでトル
エンを減圧留去した後、残渣をエタノールで2
回再結晶して3−(p−フルオロフエニル)−5
−(p′−ヘキシルオキシフエニル)イソオキサ
ゾリン8g(23%)を得た:融点104℃。(b) Add 11 g of hydroxylamide hydrochloride and 20 g of potassium hydroxide to 300 ml of an ethanol solution of 33 g of p-hersyloxybenzal-p'-fluoroacetophenone.
100 ml of an aqueous solution of 10 g was added thereto, and the mixture was refluxed for 3 hours. After cooling, dissolve the filtered precipitate in 100ml of toluene,
Washing was performed until the washing water became neutral. Next, after distilling off toluene under reduced pressure, the residue was diluted with ethanol.
After recrystallization, 3-(p-fluorophenyl)-5
8 g (23%) of -(p'-hexyloxyphenyl)isoxazoline were obtained: melting point 104°C.
実施例 2
3−(p−オクチルオキシフエニル)−5−
(p′−フルオロフエニル)イソオキサゾール
3−(p−オクチルオキシフエニル)−5−
(p′−フルオロフエニル)イソオキサゾリン2.8g
を用いて実施例1と同様な手順により、目的の3
−(p−オクチルオキシフエニル)−5−(p′−フ
ルオロフエニル)イソオキサゾール0.5g(18%)
を得た。相転移点は結晶−スメクチツク点:97.7
℃、スメクチツク−透明点:148.5℃であつた。Example 2 3-(p-octyloxyphenyl)-5-
(p'-fluorophenyl)isoxazole 3-(p-octyloxyphenyl)-5-
(p′-fluorophenyl)isoxazoline 2.8g
By the same procedure as in Example 1 using
-(p-octyloxyphenyl)-5-(p'-fluorophenyl)isoxazole 0.5g (18%)
I got it. The phase transition point is crystal-smectic point: 97.7
°C, smectic - clearing point: 148.5 °C.
実施例 3(応用例)
トランス−4−プロピル−(4′−シアノフエニ
ル)シクロヘキサン 30%重量
トランス−4−ペンチル−(4′−シアノフエニ
ル)シクロヘキサン 40%重量
トランス−4−ヘプチル−(4′−シアノフエニ
ル)シクロヘキサン 30%重量
からなる組成の液晶混合物(以下Aと略す)のネ
マチツク−透明点は52℃、誘電異方性値(以下△
εと略す)は+11.2、光学異方性値(以下△nと
略す)は0.119である。液晶セルとして酸化ケイ
素をコーテイング、ラピング処理した酸化スズ透
明電極を有する基板を対向させて組み立てた電極
間隔が10μmのものを用意し、前記液晶組成物(A)
を封入して液晶セルとし、20℃でその特性を測定
したところ、しきい値電圧1.54V、飽和電圧
2.13Vであつた。Example 3 (Application example) Trans-4-propyl-(4'-cyanophenyl)cyclohexane 30% by weight Trans-4-pentyl-(4'-cyanophenyl)cyclohexane 40% by weight Trans-4-heptyl-(4'-cyanophenyl) ) The nematic clearing point of a liquid crystal mixture (hereinafter abbreviated as A) consisting of 30% cyclohexane by weight is 52°C, and the dielectric anisotropy value (hereinafter △
ε) is +11.2, and the optical anisotropy value (hereinafter abbreviated as Δn) is 0.119. A liquid crystal cell was prepared in which substrates having tin oxide transparent electrodes coated with silicon oxide and wrapped were assembled with an electrode spacing of 10 μm, and the liquid crystal composition (A)
When the characteristics were measured at 20℃, the threshold voltage was 1.54V, and the saturation voltage was 1.54V.
It was 2.13V.
この液晶組成物(A)90重量部と本発明の実施例1
の3−(p−フルオロフエニル)−5−(p′−ヘキ
シルオキシフエニル)イソオキサゾール10重量部
とからなる組成物のネマチツク−透明点は56℃、
△εは+10.7、△nは0.128、この組成物を用い
た液晶セルのしきい値電圧は1.44V、飽和電圧は
2.03Vであつた。 90 parts by weight of this liquid crystal composition (A) and Example 1 of the present invention
The nematic clearing point of a composition comprising 10 parts by weight of 3-(p-fluorophenyl)-5-(p'-hexyloxyphenyl)isoxazole was 56°C;
△ε is +10.7, △n is 0.128, the threshold voltage of the liquid crystal cell using this composition is 1.44V, and the saturation voltage is
It was 2.03V.
実施例 4(応用例)
実施例3の液晶組成物(A)90重量部と本発明の実
施例2の3−(p−オクチルオキシフエニル)−5
−(p′−フルオロフエニル)イソオキサゾール10
重量部とからなる組成物のネマチツク−透明点は
56℃、△εは+10.3、△nは0.122、該組成物を
用いた液晶セルのしきい値電圧は、1.51V、飽和
電圧は2.04Vであつた。Example 4 (Application example) 90 parts by weight of the liquid crystal composition (A) of Example 3 and 3-(p-octyloxyphenyl)-5 of Example 2 of the present invention
-(p′-fluorophenyl)isoxazole 10
The nematic clearing point of a composition consisting of parts by weight is
At 56°C, Δε was +10.3, Δn was 0.122, the threshold voltage of the liquid crystal cell using this composition was 1.51V, and the saturation voltage was 2.04V.
この様に本発明を適用して液晶表示素子のしき
い値電圧、飽和電圧を降下させることができた。 In this manner, the threshold voltage and saturation voltage of a liquid crystal display element could be lowered by applying the present invention.
Claims (1)
のアルキル基又はアルコキシ基を示し、他方はフ
ツ素を示す)で表される3−(p−置換フエニル)
−5−(p′−置換フエニル)イソオキサゾール。 2 一般式 (式中、X又はYのいずれか一方は炭素数1〜15
のアルキル基又はアルコキシ基を示し、他方はフ
ツ素を示す)で表される3−(p−置換フエニル)
−5−(p′−置換フエニル)イソオキサゾールを
含有する液晶組成物。[Claims] 1. General formula (In the formula, either X or Y has 1 to 15 carbon atoms.
3-(p-substituted phenyl) represented by
-5-(p'-substituted phenyl)isoxazole. 2 General formula (In the formula, either X or Y has 1 to 15 carbon atoms.
3-(p-substituted phenyl) represented by
A liquid crystal composition containing -5-(p'-substituted phenyl)isoxazole.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16067283A JPS6054375A (en) | 1983-09-01 | 1983-09-01 | Isoxazole compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16067283A JPS6054375A (en) | 1983-09-01 | 1983-09-01 | Isoxazole compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6054375A JPS6054375A (en) | 1985-03-28 |
| JPH0432067B2 true JPH0432067B2 (en) | 1992-05-28 |
Family
ID=15719981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16067283A Granted JPS6054375A (en) | 1983-09-01 | 1983-09-01 | Isoxazole compound |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6054375A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10333113A (en) * | 1997-06-03 | 1998-12-18 | Sharp Corp | Liquid crystal compound, liquid crystal composition, ferroelectric liquid crystal composition, and liquid crystal display device |
| KR19990011062A (en) * | 1997-07-21 | 1999-02-18 | 손욱 | Ixoxazolidine ring-containing liquid crystal compound and liquid crystal composition containing the same |
| DE19953801A1 (en) | 1999-11-09 | 2001-05-10 | Clariant Gmbh | Novel isoxazole derivatives useful as dopants for improving the properties of liquid crystal mixtures have the isoxazole ring linked in the three and/or five position to a thiophene or furane unit |
| US6579880B2 (en) | 2000-06-06 | 2003-06-17 | Ortho-Mcneil Pharmaceutical, Inc. | Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8 |
| KR100544347B1 (en) * | 2003-12-11 | 2006-01-23 | 한국생명공학연구원 | Pharmaceutical composition for cancer prevention and treatment containing diarylisoxazole type compound as an active ingredient |
-
1983
- 1983-09-01 JP JP16067283A patent/JPS6054375A/en active Granted
Non-Patent Citations (1)
| Title |
|---|
| CHEMICAL ABSTRACTS=1982 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6054375A (en) | 1985-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4228029A (en) | Liquid crystalline compositions | |
| JPS6144863B2 (en) | ||
| JPH0428265B2 (en) | ||
| JPH0432067B2 (en) | ||
| JPS6228137B2 (en) | ||
| JPH0150694B2 (en) | ||
| JPS58126839A (en) | 4-(trans-4'-alkylcyclohexyl)benzoic acid 2,4-di-halogenophenyl ester | |
| JPS59190958A (en) | Production of biphenylpropiolnitrile | |
| JPH0150691B2 (en) | ||
| JPS6032722A (en) | 6,6'-disubstituted-2,2'-binaphthyl | |
| JPS60197637A (en) | Beta-(4-substituted phenyl)propionic acid phenyl ester derivative | |
| JPS6140271A (en) | 4-substituted-phenoxyacetic acid 4-(5-substituted-pyrimidinyl-2)phenyl ester | |
| JPS6338987B2 (en) | ||
| JPS58140086A (en) | 4-(trans-5-alkyl-1, 3-dioxa-2-yl)benzoic acid derivative | |
| JPS58121247A (en) | 3-chloro-4-halogenophenyl trans-4-(4'-substituted phenyl) cyclohexanecarboxylate | |
| JPH0565236A (en) | Fluorotran alkenyl compound | |
| JPH039895B2 (en) | ||
| JPS59157057A (en) | Ester compound | |
| JPS6261018B2 (en) | ||
| JPH0142261B2 (en) | ||
| JPS59157065A (en) | Phenylpropiolnitrile | |
| JPH0358334B2 (en) | ||
| JPH0311029A (en) | Alkoxy-alpha-methylallylbenzenes | |
| JPH0479329B2 (en) | ||
| JPS6023476A (en) | 4-(substituted carbonyloxy)biphenylyl-4'-carboxylic acid alkyl ester |